Case Study

Trusted Long-Term Partners That Sponsors Can Depend On

GettyImages-973715182-teamwork-team-collaboration-partner-partnership-relationship-agreement

PolyPid Ltd. is a Phase 3 biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics. PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with medications, enabling precise delivery of drugs at effective release rates, over durations ranging from several days to months. PolyPid’s lead product candidate D-PLEX100 is in Phase 3 clinical trials for the prevention of sternal and abdominal surgical site infections (SSIs).

PolyPid’s Phase 3 clinical trial was designed as a multi-national and multi-center study. As such, PolyPid was in need of trusted partners and the most advanced Good Clinical Practice approved technology to ensure efficient design and execution of data strategies, as well as guaranteed data accuracy and integrity.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Bioforum the Data Masters Inc.